Blair William & CO Rocket Pharmaceuticals, Inc. Transaction History
Blair William & CO
- $31.4 Billion
- Q1 2024
A detailed history of Blair William & CO transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Blair William & CO holds 147,280 shares of RCKT stock, worth $3.04 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
147,280
Previous 146,879
0.27%
Holding current value
$3.04 Million
Previous $4.4 Million
9.86%
% of portfolio
0.01%
Previous 0.02%
Shares
15 transactions
Others Institutions Holding RCKT
# of Institutions
204Shares Held
92.9MCall Options Held
341KPut Options Held
107K-
Rtw Investments, LP New York, NY17.7MShares$365 Million7.65% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$189 Million0.04% of portfolio
-
Black Rock Inc. New York, NY5.93MShares$122 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$111 Million0.0% of portfolio
-
State Street Corp Boston, MA4.19MShares$86.6 Million0.01% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.56B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...